M

Mangoceuticals Inc
NASDAQ:MGRX

Watchlist Manager
Mangoceuticals Inc
NASDAQ:MGRX
Watchlist
Price: 0.5354 USD -0.3% Market Closed
Market Cap: $7.4m

Net Margin

-4 308.4%
Current
Declining
by 2 374.4%
vs 3-y average of -1 934%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-4 308.4%
=
Net Income
$-20.1m
/
Revenue
$466.9k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-4 308.4%
=
Net Income
$-20.1m
/
Revenue
$466.9k

Peer Comparison

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 15 072 companies
5th percentile
-4 308.4%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Mangoceuticals Inc
Glance View

Market Cap
7.4m USD
Industry
Retail

Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.

MGRX Intrinsic Value
0.0434 USD
Overvaluation 92%
Intrinsic Value
Price
M
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-4 308.4%
=
Net Income
$-20.1m
/
Revenue
$466.9k
What is Mangoceuticals Inc's current Net Margin?

The current Net Margin for Mangoceuticals Inc is -4 308.4%, which is below its 3-year median of -1 934%.

How has Net Margin changed over time?

Over the last 2 years, Mangoceuticals Inc’s Net Margin has decreased from -2 588.2% to -4 308.4%. During this period, it reached a low of -4 308.4% on Oct 30, 2025 and a high of -1 052.9% on Jun 30, 2024.

Back to Top